Charles Albright Editas Medicine, Inc. (EDIT) insider trading activity

Charles Albright is EVP/Chief Scientific Officer of Editas Medicine, Inc.. Currently has a direct ownership of 24,907 shares of EDIT, which is worth approximately $30,137. The most recent transaction as insider was on Dec 15, 2020, when has been sold 10,000 shares (Common Stock) at a price of $63.66 per share, resulting in proceeds of $636,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.9K

0% 3M change

0% 12M change

Total Value Held $30,137

Charles Albright Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 15 2020	SELL Open market or private sale	$636,600 $63.66 p/Share	10,000 Reduced 28.65%	24,907 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$165,100 $16.51 p/Share	10,000 Added 22.27%	34,907 Common Stock
Dec 09 2020	SELL Open market or private sale	$450,000 $45.0 p/Share	10,000 Reduced 28.65%	24,907 Common Stock
Dec 09 2020	BUY Exercise of conversion of derivative security	$165,100 $16.51 p/Share	10,000 Added 22.27%	34,907 Common Stock
Dec 07 2020	SELL Open market or private sale	$800,400 $40.02 p/Share	20,000 Reduced 44.54%	24,907 Common Stock
Dec 07 2020	BUY Exercise of conversion of derivative security	$330,200 $16.51 p/Share	20,000 Added 30.81%	44,907 Common Stock
Nov 09 2020	SELL Open market or private sale	$7,116 $31.21 p/Share	228 Reduced 0.91%	24,907 Common Stock
Oct 15 2020	SELL Open market or private sale	$94,170 $31.39 p/Share	3,000 Reduced 10.66%	25,135 Common Stock

Charles Albright

EVP/Chief Scientific Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EDIT shares.

Notify only if

Value

Insider Trading

Get notified when an Editas Medicine, Inc. insider buys or sells EDIT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Editas Medicine, Inc.

Track Activities on EDIT

Account